Introduction: Maxillary sinus augmentation is a predictable implant site development technique
Residual alveolar bone height (RBH) is a critical anatomic factor that is carefully considered when planning a maxillary sinus augmentation procedure. Given its direct influence on implant primary stability, RBH is commonly used to determine the implant placement protocol of choice, either simultaneous or delayed. Abundant and compact residual alveolar bone favors implant primary stability. Conversely, achieving primary stability is often challenging in sites exhibiting limited and coarse alveolar bone. In the vast majority of maxillary sinus augmentation protocols, the cut-off value to discern whether to perform simultaneous or delayed implant placement is in the range of 4 to 6 mm of RBH (Wang & Katranji 2008; Misch et al. 2009; Nkenke & Stelzle 2009 ). Interestingly, high implant survival rates have been extensively reported in challenging clinical scenarios, where implants were simultaneously placed with <5 mm of RBH (Peleg et al. 1998 (Peleg et al. , 1999 (Peleg et al. , 2006 Rodriguez et al. 2003; Mardinger et al. 2007) . Therefore, the impact of RBH on implant stability and survival has been the subject of investigation (Fenner et al. 2009a is not exclusively related to implant stability and implant success/survival rates. The success of any bone grafting procedure, including maxillary sinus augmentation, relies on the provision of adequate angiogenesis and migration of osteogenic cells from native bone (Busenlechner et al. 2009 ). Therefore, it has been suggested and it can be hypothesized that residual alveolar bone, as a foundational source of cells and blood supply, may play an important role in the consolidation and maturation of a maxillary sinus graft.
This case series study was aimed at evaluating the influence of RBH on histomorphometric outcomes, such as proportion of vital bone (%VB) and remaining allograft particles (%RA), following sinus augmentation using an allogenic grafting material.
Material and methods

Patients
All participants in the study were recruited and treated in the Graduate Periodontics Clinic at the University of Michigan School of Dentistry. The University of Michigan Institutional Review Board approved the experimental protocol (HUM00017520). The study was also registered in the database of the National Institutes of Health (NIH) (http://www.clinicaltrials.gov) under the identification number 'NCT00868777'. Adult patients between 18 and 85 years of age, in need of unilateral or bilateral sinus augmentation with delayed implant placement, presenting physical status according to the American Society of Anesthesiologists (ASA) of I or II (http://www.asahq.org/clinical/physicalstatus.htm), exhibiting RBH 6 mm (assessed in periapical radiographs taken with the paralleling technique), and O'Leary plaque score 20% (O'Leary et al. 1972 ) were included in the study. Patients were excluded from the study if reported long-term (>2 weeks) use of antibiotics within the previous 3 months, use of medications known to affect bone metabolism, uncontrolled conditions known to alter bone metabolism, smoking more than 10 cigarettes per day (Levin et al. 2004 ), history of alcoholism or recreational drug abuse, mucocutaneous diseases, severe acute or chronic sinus pathology (i.e. sarcoidosis, osteomas, carcinomas), history of cancer, radiation to the head and neck in the last 18 months, and chemotherapy in the last 12 months or postoperative complications related to these therapies. Female patients who were pregnant or attempting to get pregnant at the time of screening were also excluded. Prior to inclusion in the study, patients were required to read, understand, and sign an informed consent form.
Surgical planning
Stone models of all patients were obtained from upper and lower alginate impressions. Customized radiographic guides were fabricated, as described elsewhere (Avila et al. 2010b ). Cone-beam computed tomography (CBCT) scans were obtained from each patient using an i-CAT cone-beam machine (Imaging Sciences International, Inc, Hatfield, PA, USA). Only the maxilla and maxillary sinuses were scanned in these patients to minimize the radiation exposure unless a request to include the mandible or other areas of the skull in the same scan was made for other purposes not related to this research study. The Field of View (FOV) used was 6 cm for the maxilla and maxillary sinuses only, 8 cm when both jaws were included in the scan, and 13 cm for the entire head. The machine settings are fixed at 120 kVp and 18.66 mAs for all scans regardless of the FOV used. Linear measurements to determine the RBH were made using a radiopaque cylindrical marker embedded in the guide as reference (Fig. 1) . Proprietary software provided by the manufacturer of the scanner was used for these measurements (iCAT; Xoran Technologies Inc., Ann Arbor, MI, USA). Two calibrated, blinded examiners specifically trained for this project performed the measurements twice. Measurements were averaged and expressed as the mean value between the average of the two sets of measurements that were independently obtained by each examiner.
All participants were asked to follow a pharmacologic protocol consisting of antibiotics (Amoxicillin 500 mg TID for 10 days, starting 2 days before the surgery; or clindamycin 300 mg TID for 10 days, starting 2 days before the surgery, for patients allergic to penicillins) and oral corticosteroids (Dexamethasone 8 mg QD, 24 h before the surgery) to control postoperative swelling and discomfort.
Maxillary sinus augmentation
Surgeries were performed under intravenous sedation and local anesthesia (xylocaine 2% 1:100,000 or 1:50,000; Astra Zeneca USA, Inc., Pharmaceuticals, Westborough, MA, USA). In all cases, sinus augmentation was performed following a lateral approach. Fig. 1 . Linear measurements using the radiopaque marker of the guide as a reference were performed to assess the residual bone height (RBH).
Briefly, a supracrestal incision was made on the edentulous segment, with vertical releases if needed to facilitate surgical access. Following full-thickness flap elevation, a lateral window was prepared with a round diamond bur. After exposure of the Schneiderian membrane, specifically designed hand instruments were used for its elevation (Salvin Dental Specialties, Inc., Charlotte, NC, USA). A mineralized bone allograft with particle size ranging from 600 to 1250 lm (MinerOss ® ; BioHorizons Inc., Birmingham, AL, USA) was used as the sole grafting material. Liquid antibiotic (clindamycin 150 mg/ ml) was added to the bone graft to minimize the incidence of postoperative infection, using a 1 ml of antibiotic to 2 ml of grafting material ratio. An absorbable collagen material (Collatape ® ; Zimmer Dental, Carlsbad, CA, USA) was placed over the window for hemostatic purposes. Soft tissues were sutured attempting primary closure.
Postoperative instructions were provided after completion of the surgical procedure. Subjects were instructed to take the corticosteroid in decreasing daily doses of 6, 4, and 2 mg starting the day of the surgery. Patients returned for a postoperative follow-up and suture removal at 2 weeks. Thereafter, they were evaluated at 1, 2, 3, 4, and 5 months after maxillary sinus augmentation. Oral hygiene instructions and supragingival deplaquing, if needed, were provided at these visits.
Bone core biopsy harvesting
At the 5-month follow-up visit, a second CBCT scan utilizing the radiographic guide was obtained. All of the follow-up CBCT scans included the maxilla and maxillary sinuses only. The FOV used was 6 cm and the machine settings were fixed at 120 kVp and 18.66 mAs. An analysis of the grafted area was conducted to assess total bone height achieved and to plan the implant placement surgery, which was performed in all cases between 6 and 7 months after sinus augmentation. Implant placement was performed under local infiltrative anesthesia. The customized radiographic guide was transformed into a surgical guide designed to allow the use of a 3.75 mm diameter trephine (Salvin Dental Specialties, Inc.), to obtain samples from the exact locations where the radiographic measurements were made. Implant diameter was ! 4 mm in all cases; therefore, in some cases, no drill was utilized after the trephine. Implants were placed in a submerged approach with a minimum insertion torque of 30 N/cm 2 to ensure primary stability, following the manufacturer's instructions (BioHorizons Internal Implants; BioHorizons Inc., Birmingham, AL, USA).
Histologic preparation
Immediately after harvesting, biopsies were submerged in a 10% neutral buffered formalin solution for fixation. Following demineralization in EDTA, cores were dehydrated and embedded in paraffin. Specimens were sectioned following a protocol to accurately obtain circular analyzable samples (Fig. 2) . Samples were stained with a conventional hematoxylin-eosin technique and coverslipped for histologic and histomorphometric analysis.
Histomorphometric analysis
Eight randomized images per sample were captured using a bright field optical microscope with a digital camera (Nikon E800 Light microscope with Diagnostics Spot-RT cooled CCD digital camera, Tokyo, Japan) connected to a computer containing specialized software (Image-Pro Plus 5.0; Media Cybernetics, Bethesda, MD, USA). Vital bone (VB), remaining allograft particle (RA), and non-mineralized tissue (NMT) proportions were measured separately by an experienced examiner (Fig. 3) .
Statistical analyses
All recorded variables (RBH, %VB, %RA, and %NMT) were expressed as mean values. The association of RBH with %VB and %RA was quantified as a Pearson's correlation coefficient. RBH was further divided into two categories: <4 and ! 4 mm. Subsequently, a categorical analysis of correlation was performed for the parameters %VB and %RA. The statistical significance of each correlation coefficient estimate was expressed as a P-value, where P < 0.05 was considered statistically significant. The correlation coefficients obtained were adjusted for age and gender by calculating partial correlation coefficients.
Results
Subjects and radiographic findings
Nine male patients and twelve female patients with a mean age of 57.6 years (ranging from 23 to 69 years) participated in the study. After initial CBCT analysis, four patients were referred for otorhinolaryngological consultation, and all of them were cleared for the procedure. Mean baseline radiographic RBH was 4.25 ± 1.56 mm, ranging from 1.4 to 6.6 mm.
Inter-rater agreement coefficient for RBH was 0.988, which illustrates a robust positive correlation between measurements made by the two examiners. A total of 21 sinus augmentation procedures were performed. One patient developed a sinusal infection during the initial 2 weeks following bone augmentation. This patient was treated accordingly and the infection was controlled, but was still excluded from the study. All remaining twenty patients were regularly followed-up for the 6-month healing period. In all these cases, augmentation achieved 6 months after sinus augmentation allowed proper implant placement. Mean ridge height achieved after sinus augmentation was 15.9 ± 2.9 mm, ranging from 12 to 21.6 mm.
Histomorphometric analysis
Twenty bone biopsies were obtained and sections at a distance of 10 mm from the alveolar crest were prepared for histomorphometric evaluation. Analysis of hematoxylineosin sections revealed the presence of three tissue components: VB, RA, and NMT. The NMT was compatible with connective tissue presenting two different, coexisting patterns: fibrous and adipose, both in the presence of randomly distributed blood vessels. Newly formed vital bone and remaining allograft particles were basically distinguishable by the presence of osteocytes in the lacunae. Bonelining cells (osteoblasts) were observed over well-organized lamellar bone. Most remaining allograft particles were in intimal contact with newly formed bone, which supports the osteoconductive properties of the material used (Fig. 4) . Mean %VB was 20.47 ± 18.25, mean %RA was 29.04 ± 24.94, and a total of 50.47 ± 12.76 was found for mean percentage of NMT. Histomorphometric data are expressed in the form of a graphic bar diagram in Fig. 5 . In addition, histomorphometric analysis results in relation to RBH for each sinus are reported in Table 1 .
Analysis of correlation
The correlation between radiographic RBH, RBH <4 mm, and RBH ! 4 mm, and both % VB and %RA was analyzed using linear regression analysis (Scatter plot displayed in Fig. 6 ). No significant correlation between RBH and %VB (r = 0.016; P = 0.951), and RBH and %RA (r = 0.009; P = 0.971) was found when all data were pooled. Categorical analysis of correlation after stratification of RBH revealed no statistically significant correlation for any of the associations considered (Table 2 ). In light of these results, remaining alveolar bone height does not appear to influence the maturation and consolidation of an allograft in the maxillary sinus.
Discussion
RBH is a key factor to consider prior to sinus augmentation. For most clinicians, RBH determines if implant can be simultaneously placed or not, as RBH may influence the possibility of achieving implant primary stability. The higher the RBH, the better is the chance of achieving primary implant stability. Remaining bone heights of 4 and 6 mm have been proposed as the minimum height that can assure a reliable, simultaneous implant placement. Fenner and coworkers tested the hypothesis that a minimum RBH is required to obtain better outcomes using an animal model (i.e. minipigs).
In their study, the alveolar ridge was surgically remodeled, leaving the crestal aspect intact, to create four different groups (two specimens per group) based on the RBH: 2, 4, 6, and 8 mm. Then, the sinus was grafted and implants were simultaneously placed (six per specimen). Implant stability was assessed using resonance frequency analysis (RFA) at the time of implant placement, 6 months after placement, and 6 months after functional loading. At that time, animals were sacrificed and samples including the implants were retrieved to histologically analyze bone-to-implant contact (BIC) ratio, interthread bone area, peri-implant bone area, and crestal bone resorption. It was concluded that although implant stability and BIC values were worse in the groups with less RBH, the threshold of 5 mm is not scientifically supported, as osseointegration and implant survival were not significantly affected (Fenner et al. 2009a,b) . In a prospective clinical series study using private practice patients, Urban and Lozada compared the success and survival rate of implants placed following a two-stage approach in clinical scenarios with minimal RBH ( 3.5 mm) and patients with moderate residual crestal bone (3.5-7 mm). One hundred and fifty-six of 245 implants were placed in the minimal RBH group. Only one implant failed, at the time of abutment placement, and three more failed to meet the success criteria, after 5 years from abutment connection. Overall, implant success and survival rate in this group were 94.1% and 99.4%, respectively. On the other hand, implant success and survival rate were both 100% in the moderate RBH group. Interestingly, these differences were not statistically significant (Urban & Lozada 2010) . These results are in agreement with the observations reported in a systematic review aimed at assessing the influence of RBH on the survival of implants placed simultaneously or delayed after sinus augmentation. Data reviewed from available literature suggest that higher implant survival rate can be expected with higher RBH. Nonetheless, the implant survival rate associated with simultaneous implant placement in the presence of less than 5 mm of RBH was found to be very similar to that in cases of RBH higher than or equal to 5 mm, being 96% and 99%, respectively (Rios et al. 2009 ). Nevertheless, besides implant stability and survival rate, RBH may also play an important role in the osteogenic potential of the grafted area following maxillary sinus augmentation. New vital bone formation rate, as part of the process of graft consolidation, has been proposed as primarily dependent on the native maxillary bone (Zijderveld et al. 2005) . It is important to highlight that bone formation is not exclusively related to the migration and activity of osteogenic cells derived from native bone. The importance of angiogenesis in human bone healing has been greatly emphasized (Carano & Filvaroff 2003) . Microvascular density is essential in graft consolidation, although each biomaterial allows different microvascular colonization (Boeck-Neto et al. 2009; GalindoMoreno et al. 2010) . Zerbo et al. (2004) showed, using the sinus augmentation model, that b-TCP particles lying directly over residual bone of the maxilla were partially or completely replaced by vital bone after 6 months, whereas particles located more apical were still present, suggesting a coronal to apical graft consolidation. Tadjoedin et al. (2003) , showed that the front of bone growth primarily originates from the pre-existing native bone surfaces of the maxillary sinus, particularly from the residual alveolar bone. This concept has been recently confirmed by Busenlechner and collaborators, who demonstrated that bone formation is significantly higher in the interface of native bone with different grafting materials, than in deeper areas. However, the gradient of graft consolidation is characteristic of each biomaterial, as reflected by the osteogenic response of the host bone and the degradation profile of the applied bone substitutes (Busenlechner et al. 2009 ). Our group has previously reported maxillary sinus dimensions influence vital bone formation (Avila et al. 2010a) . Similar findings were reported by Artzi et al. (2005) , who described that bone area fraction, comparing b-TCP and anorganic bovine bone, increased from peripheral to deeper zones. In the present study, we aimed at evaluating the influence of RBH upon the formation of vital bone and the presence of remaining particles using an allograft as a sole grafting material for maxillary sinus augmentation. No significant, either positive or negative, correlation was observed between radiographic RBH and both %VB (R 2 = 0.248; P = 0.126) and %RA (R 2 = À0.065; P = 0.384), even when RBH was stratified into two groups using 4 mm as the cut-off value. There was a non-linear relationship for both parameters, as it can be observed in the scatter plots included in Fig. 6 . Our findings are in agreement with previously discussed available studies indi- cating that RBH may not be such a critical factor to achieve successful outcomes following maxillary sinus augmentation. However, our aim was to evaluate initial maxillary sinus outcomes, instead of long-term implant or implant-supported prostheses success/survival rate. It is possible that implant and implant-supported restorations survival is influenced by the amount of remaining alveolar bone after functional loading. A posthoc power analysis calculation, performed using a specialized software (Faul et al. 2007) , revealed that the study has a power of 68%. It is generally acknowledged that 85% is the standard power required to reject the null hypothesis when it is truly false. This suggests that further studies based on an a priori power analysis with RBH as the primary outcome, using the information presented in this pilot study, should be conducted to shed more light on this interesting topic. Furthermore, another limitation of this study stems from the interindividual variability in histomorphometric outcomes, particularly in terms of vital bone and remaining allograft particle, as reflected in Table 1 and Fig. 5 . Despite our efforts to enroll a homogeneous patient population, based on the inclusion and exclusion criteria, this marked variability could be explained by individual healing potential, and other confounders such as the occurrence of concomitant respiratory tract pathology (e.g. common viral cold) during the healing period. The use of prophylactic antibiotics prior to sinus augmentation procedures is a controversial topic. In general, the use of antibiotic prophylaxis is generally limited to those cases in which there is a concomitant local infection and when patients with comorbid conditions or immunodepression are treated. The rationale is to avoid pharmacologic allergic reactions and antibiotic resistances. Interestingly, Powell et al. (2005) , showed that patients who received antibiotics exhibited a higher rate of infection than patients who had no antibiotic coverage, although the difference was not statistically significant. In the population they studied, no patient who underwent maxillary sinus augmentation (n = 15) developed an infection. However, 'the prophylactic use of systemic and local antibiotics and glucocorticosteroids can reduce the risk of infection' (Misch 1992) . This recommendation finds a clear indication in the event of Schneiderian membrane perforation, since a retrograde bacterial colonization from the respiratory tract may lead to an infection of the grafted area. Given the impossibility of predicting in which cases that complication is going to occur, to provide a standardized treatment to all patients participating in this controlled study, we followed the pharmacologic protocol proposed by Resnik & Misch (2008) . Finally, to our knowledge, there is limited information available with regard to impact of local antibiotic application in the healing following oral bone grafting and conflicting results have been reported (Kim et al. 2004; Oghli & Steveling 2010) . We consider that, although possible, it is unlikely that the use of liquid clindamycin in conjunction with the bone grafting material has a determining influence in bone healing and histomorphometric values of samples harvested after a 6-month healing period.
Conclusions
Our findings suggest that remaining alveolar bone height does not influence the maturation and consolidation of an allograft 6 months after maxillary sinus augmentation.
